NCT07022002 2025-08-03
SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid Tumors
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 2 Recruiting
Shenyang Sunshine Pharmaceutical Co., LTD.
Regeneron Pharmaceuticals
pharmaand GmbH
AbbVie
Daiichi Sankyo
MyGenostics Inc., Beijing